Empagliflozin promises to bridge the gap between non-alcoholic fatty liver disease, type 2 diabetes, and cardiovascular disease

Saved in:
Bibliographic Details
Main Authors: Dimitrios Patoulias, Maria Kalogirou
Format: Article
Language:English
Published: Termedia Publishing House 2018-12-01
Series:Gastroenterology Review
Online Access:https://www.termedia.pl/Empagliflozin-promises-to-bridge-the-gap-between-non-alcoholic-fatty-liver-disease-type-2-diabetes-r-nand-cardiovascular-disease,41,34212,1,1.html
Tags: Add Tag
No Tags, Be the first to tag this record!